Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Psychopharmacology (Berl). 2011 Oct 1;220(4):673–685. doi: 10.1007/s00213-011-2516-9

Table 2.

Cocaine discrimination accuracy at criteria and dose-effect curve

Genotype %DAR saline %DAR cocaine A50 DAR A50 rate reduction
Wild-type 1.9 ± 0.6 98.6 ± 0.5 1.49 [1.04 – 2.14] 9.77 [8.22 – 11.6]
M1−/− 1.0 ± 0.6 97.4 ± 0.8 2.05 [1.23 – 3.43] 11.8 [7.42 – 16.6]
M4−/− 1.2 ± 0.4 98.6 ± 0.7 1.49 [0.69 – 3.19] 10.3 [6.42 – 16.5]

%DAR saline and %DAR cocaine represent average performance over the block of sessions that satisfied discrimination criteria (group means ± s.e.m.). Group sizes: wild-type, N = 13, M1−/−, N = 9, M4−/− mice, N = 8. Reductions in response rates by at least 50% were not observed in all of the subjects, and A50 for rate reduction was calculated from 12 wild-type mice, 5 M1−/− mice, and 6 M4−/− mice.

HHS Vulnerability Disclosure